Literature DB >> 23569252

Intercellular trafficking of the nuclear oncoprotein DEK.

Anjan K Saha1, Ferdinand Kappes, Amruta Mundade, Anja Deutzmann, David M Rosmarin, Maureen Legendre, Nicolas Chatain, Zeina Al-Obaidi, Barbara S Adams, Hidde L Ploegh, Elisa Ferrando-May, Nirit Mor-Vaknin, David M Markovitz.   

Abstract

DEK is a biochemically distinct, conserved nonhistone protein that is vital to global heterochromatin integrity. In addition, DEK can be secreted and function as a chemotactic, proinflammatory factor. Here we show that exogenous DEK can penetrate cells, translocate to the nucleus, and there carry out its endogenous nuclear functions. Strikingly, adjacent cells can take up DEK secreted from synovial macrophages. DEK internalization is a heparan sulfate-dependent process, and cellular uptake of DEK into DEK knockdown cells corrects global heterochromatin depletion and DNA repair deficits, the phenotypic aberrations characteristic of these cells. These findings thus unify the extracellular and intracellular activities of DEK, and suggest that this paracrine loop involving DEK plays a role in chromatin biology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23569252      PMCID: PMC3637753          DOI: 10.1073/pnas.1220751110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Cellular uptake of exogenous human PDCD5 protein.

Authors:  Ying Wang; Dan Li; Hui Fan; Linjie Tian; Yingcheng Zhong; Yingmei Zhang; Lan Yuan; Caining Jin; Caihua Yin; Dalong Ma
Journal:  J Biol Chem       Date:  2006-06-05       Impact factor: 5.157

2.  Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.

Authors:  Luis Miguel Mendes Soares; Katia Zanier; Cameron Mackereth; Michael Sattler; Juan Valcárcel
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

3.  The DEK nuclear autoantigen is a secreted chemotactic factor.

Authors:  Nirit Mor-Vaknin; Antonello Punturieri; Kajal Sitwala; Neil Faulkner; Maureen Legendre; Michael S Khodadoust; Ferdinand Kappes; Jeffrey H Ruth; Alisa Koch; David Glass; Lilli Petruzzelli; Barbara S Adams; David M Markovitz
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

4.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

5.  High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin.

Authors:  De Yang; Qian Chen; Huan Yang; Kevin J Tracey; Michael Bustin; Joost J Oppenheim
Journal:  J Leukoc Biol       Date:  2006-09-11       Impact factor: 4.962

6.  The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity.

Authors:  Ferdinand Kappes; Tanja Waldmann; Veena Mathew; Jindan Yu; Ling Zhang; Michael S Khodadoust; Arul M Chinnaiyan; Karolin Luger; Sylvia Erhardt; Robert Schneider; David M Markovitz
Journal:  Genes Dev       Date:  2011-04-01       Impact factor: 11.361

7.  DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.

Authors:  F Kappes; J Fahrer; M S Khodadoust; A Tabbert; C Strasser; N Mor-Vaknin; M Moreno-Villanueva; A Bürkle; D M Markovitz; E Ferrando-May
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

8.  Melanoma proliferation and chemoresistance controlled by the DEK oncogene.

Authors:  Michael S Khodadoust; Monique Verhaegen; Ferdinand Kappes; Erica Riveiro-Falkenbach; Juan C Cigudosa; David S L Kim; Arul M Chinnaiyan; David M Markovitz; María S Soengas
Journal:  Cancer Res       Date:  2009-08-15       Impact factor: 12.701

9.  FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.

Authors:  Roya Babaei-Jadidi; Ningning Li; Anas Saadeddin; Bradley Spencer-Dene; Anett Jandke; Belal Muhammad; ElSayed E Ibrahim; Ranjithmenon Muraleedharan; Mohammed Abuzinadah; Hayley Davis; Annabelle Lewis; Susan Watson; Axel Behrens; Ian Tomlinson; Abdolrahman Shams Nateri
Journal:  J Exp Med       Date:  2011-01-31       Impact factor: 14.307

10.  The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer.

Authors:  L M Privette Vinnedge; R McClaine; P K Wagh; K A Wikenheiser-Brokamp; S E Waltz; S I Wells
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

View more
  19 in total

1.  Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

Authors:  Maegan L Capitano; Nirit Mor-Vaknin; Anjan K Saha; Scott Cooper; Maureen Legendre; Haihong Guo; Rafael Contreras-Galindo; Ferdinand Kappes; Maureen A Sartor; Christopher T Lee; Xinxin Huang; David M Markovitz; Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

Review 2.  Thirty years of intracrinology.

Authors:  Richard N Re
Journal:  Ochsner J       Date:  2014

Review 3.  The DEK oncoprotein and its emerging roles in gene regulation.

Authors:  C Sandén; U Gullberg
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

4.  The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.

Authors:  A Deutzmann; M Ganz; F Schönenberger; J Vervoorts; F Kappes; E Ferrando-May
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

Review 5.  A role for intracellular and extracellular DEK in regulating hematopoiesis.

Authors:  Maegan L Capitano; Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

6.  Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells.

Authors:  Yao-Shun Yang; Xi-Zheng Jia; Qian-Yun Lu; Sun-Li Cai; Xue-Ting Huang; Shu-Hua Yang; Chris Wood; Yue-Hong Wang; Jiao-Jiao Zhou; Yi-Ding Chen; Jin-Shu Yang; Wei-Jun Yang
Journal:  Oncogene       Date:  2022-03-29       Impact factor: 9.867

7.  Potential of DEK proto-oncogene as a prognostic biomarker for colorectal cancer: An evidence-based review.

Authors:  Muhammad Habiburrahman; Muhammad Prasetio Wardoyo; Stefanus Sutopo; Nur Rahadiani
Journal:  Mol Clin Oncol       Date:  2022-05-26

Review 8.  Pairing and anti-pairing: a balancing act in the diploid genome.

Authors:  Eric F Joyce; Jelena Erceg; C-Ting Wu
Journal:  Curr Opin Genet Dev       Date:  2016-04-09       Impact factor: 5.578

Review 9.  Concise review: role of DEK in stem/progenitor cell biology.

Authors:  Hal E Broxmeyer; Nirit Mor-Vaknin; Ferdinand Kappes; Maureen Legendre; Anjan K Saha; Xuan Ou; Heather O'Leary; Maegan Capitano; Scott Cooper; David M Markovitz
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

Review 10.  Heparan sulfate in the nucleus and its control of cellular functions.

Authors:  Mark D Stewart; Ralph D Sanderson
Journal:  Matrix Biol       Date:  2013-12-03       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.